Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.
about
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant EpitopeThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesTetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin AmericaProtective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus InfectionDengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccineDengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.Antibodies against immature virions are not a discriminating factor for dengue disease severity.Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohortDengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive AntibodiesEvolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool.Immune correlates of protection for dengue: State of the art and research agenda.Zika Virus: Immunity and Vaccine Development.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections.Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by a combination of three simple serological tests.Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus.Antibody-dependent enhancement of severe dengue disease in humans.The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory.Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
P2860
Q26700120-A30B1B15-35BD-414D-8D5B-4AB6BD6125D3Q26995782-5FC3CB3B-65D5-450A-9077-FD324472A73DQ27304342-3C0680A8-CC9F-4E7B-A047-5E12522C2896Q27468944-7859611A-F3D0-4580-B240-6F3B6FC84344Q28119679-FE5CAD90-CC6D-4EB8-963D-9AA863BC0E9DQ34042859-F7CC5A00-3C9B-48F1-9E07-18AEE1971584Q34262245-E9C35E4F-02D3-4892-AA99-927E12567282Q34351011-ADBB3A02-302F-485A-A3E7-658B97869C27Q35168403-167A478E-3445-4A36-A69C-D65C79B9F706Q35221318-98645FBD-28BF-461D-9294-5C7418423A0AQ35294150-9068EFE7-0B4F-492F-9099-A1F56B7822C2Q35758626-D5030D4A-F3ED-4393-9E58-146D8040A743Q36597801-7D77A1C2-9677-454C-BEF9-EEC1C38A2322Q37363501-8900B46D-AF7F-4AA4-BECA-0E486F02741DQ38652971-242B170A-DB12-4882-89F8-850B8D7B25A0Q38969772-13DC5E7E-CF83-4A00-AC94-AA258C14ABE0Q39535403-95A634B9-F913-4A50-A304-8144FA241CB6Q40038877-5D24AFC5-25F4-4720-81E1-5E463B27550DQ41918088-46A22C71-E573-4C81-B03A-92EC09738BB6Q42985743-3EFD11C3-AC04-49DF-9B5D-B36DB87CB610Q45324313-D7775CB3-56A9-4766-A39E-6329C4198307Q47156413-7452E8EE-9CA0-47EB-8D6C-445251054813Q47592202-36695628-9EFD-43FF-A553-3CCC014EA675Q51782689-1C1375FA-285C-44F8-84F3-5BBD43673A4DQ53711324-B43931A1-7E13-46DF-A195-4D3371CC79E8Q54215484-E22879C7-4D55-4C2D-AADC-DCE0892F7A03
P2860
Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@ast
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@en
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@nl
type
label
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@ast
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@en
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@nl
prefLabel
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@ast
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@en
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@nl
P2093
P2860
P50
P921
P1476
Analysis of cross-reactive ant ...... rs in Nicaraguan dengue cases.
@en
P2093
Chih-Yun Lai
Katherine L Williams
Sarah Knight
Yi-Chieh Wu
P2860
P356
10.1371/JOURNAL.PNTD.0002451
P407
P577
2013-09-19T00:00:00Z